# Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions

> **NCT00803764** · PHASE1 · COMPLETED · sponsor: **Perrigo Company** · enrollment: 34 (actual)

## Conditions studied

- Bioequivalency

## Interventions

- **DRUG:** Naproxen Tablets, 500 mg

## Key facts

- **NCT ID:** NCT00803764
- **Lead sponsor:** Perrigo Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2004-07
- **Final completion:** —
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00803764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00803764, "Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00803764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*